The company removed the devices from the market in February following complaints of the syringes disconnecting from manifolds.
WASHINGTON, DC—The routine use of angiographic follow-up after PCI failed to reduce the risk of clinical events among a group of “all comer” patients treated for coronary disease, according to the ...
The global angiographic catheters market is projected to witness steady and robust growth over the next decade, according to recent industry projections. Valued at USD 1.5 billion in 2025, the market ...
Please provide your email address to receive an email when new articles are posted on . Moderate to severe angiographic vasospasm was detected more often in controls than in those given implants. At ...
Your catheter should be engaged in a coaxial fashion with the coronary ostium and should “seat” well, allowing contrast injections to fill the artery lumen. For the left coronary and dilated aortic ...
Arterial hypertension is known as a major risk factor for several ocular and systemic diseases. Despite new and efficient antihypertensive drugs, hypertension is still associated with significant ...
Please provide your email address to receive an email when new articles are posted on . The FDA has identified Cordis’ recall of its angiographic catheter with radiopaque marker bands as Class I, the ...
The Global Angiographic Catheters Industry is gearing up for a period of substantial growth, with a projected valuation of US$ 2,215.4 million by the year 2033. This promising ascent represents a ...
RECENT advances in the surgical treatment of dissecting aneurysm of the thoracic aorta, based on resection and graft replacement of a segment of aorta including the intimal tear, have made ...
WESTMINSTER, Colo., Oct. 10, 2012 /PRNewswire/ -- Surefire Medical, Inc. announced today that the company has received 510(k) FDA clearance to market its line of Surefire Angiographic Catheters.
New-generation coronary stents that release zotarolimus or everolimus have been shown to reduce the risk of restenosis. However, it is unclear whether there are differences in efficacy and safety ...
Purpose To evaluate the angiographic characteristics of recurrent choroidal neovascularization (R-CNV) in age-related macular degeneration (AMD). Methods A prospective investigation on 107 consecutive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results